Age (years), mean ± SD |
10.7±2.5 |
10.4±2.3 |
11.3±2.7 |
0.19 |
Symptoms during COVID-19 infection, n(%)
Cough
Fever
Rhinitis
Sore throat
Dyspnea
Fatigue
|
35 (62.5)
35 (62.5)
28 (50)
14 (25)
3 (5.4)
2 (3.6)
|
20 (57.1)
20 (57.1)
16 (45.7)
10 (28.6)
1 (2.9)
0 (0)
|
15 (71.4)
15 (71.4)
12 (57.1)
4 (19.1)
2 (9.5)
2 (9.5)
|
0.29
0.29
0.58
0.53
0.55
0.14
|
Overweight or obesity, n (%) |
15 (26.8) |
10 (28.6) |
5 (23.8) |
0.70 |
History of atopy |
1 (1.8) |
0 (0) |
1 (4.8) |
0.38 |
Diagnosis COVID-19 infection, n (%)
Mild/URI
Moderate/Pneumonia
|
|
|
|
0.20
|
|
43 (76.8)
13 (23.2)
|
29 (82.9)
6 (17.1)
|
14 (66.7)
7 (33.3)
|
|
SpO2 (%), mean ± SD |
98.6±1 |
98.5 ±1 |
98.9±1 |
0.11 |
Pulmonary function, mean ± SD
FEV1 z-score
FVC z-score
FEV1/FVC (%) z-score
|
0.53±1.18
0.61±1.21
-0.08±1.09
|
0.88±1.11
0.85±1.12
0.05±0.87
|
-0.06±1.18
0.20±1.48
-0.30±1.38
|
0.003
0.052
0.25
|
Time since the last COVID-19 infection (days), mean ± SD |
98.4±26.6 |
96.2±26.7 |
102±26.9 |
0.45 |
Pulmonary function impairment on spirometry, n (%)
Low FEV1/FVC
Isolated Low FEV1
Isolated Low FVC
|
10 (17.9)
6 (10.7)
1 (1.8)
3 (5.4)
|
-
-
-
-
|
10 (41.6)
6 (28.6)
1 (4.8)
3 (14.3)
|
N/A
|